sickle cell, breaking the sickle

‘Breaking the Sickle’ Children’s Book Co’s Plan to Combat Sickle Cell

*Melanin Origins LLC, a children’s book company that writes biographies of African-American leaders, has partnered with Sickle Cell Disease Association of North Texas (SCDANT) in effort to increase the quality of life for those living with sickle cell conditions. The partnership includes Melanin Origins donating 25% of the proceeds from their latest book, Breaking The Sickle: A Snippet of The Life of Dr. Yvette Fay Francis-McBarnette to SCDANT.

The late Dr. Francis-McBarnette was a pioneer in treating patients battling sickle cell anemia. The work that she did helped prolong lives and improve the quality of life for patients around the world. Former President Nixon created policies and initiatives that greatly impacted the nation due to the groundbreaking work of Dr. Francis-McBarnette.

SCDANT is a 501(c)3 organization committed to providing meaningful support for persons living with sickle cell conditions, as well as promoting awareness in the community. In addition to hosting blood drives, funding research, visiting hospitals, and volunteering initiatives, SCDANT offers programs aimed at off-setting qualifying expenses incurred due to having sickle cell.

It is clear what makes this partnership special: the promotion of literacy, providing hope to children, and giving back to a resilient community of people who champion living and surviving conditions that they did not ask for.

The mission of Melanin Origins LLC is to provide quality education materials which inspire young minds to aspire for excellence while embracing their heritage.

More information can be found about this partnership at

Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. People with this disorder have atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape.







Louie T. McClain II
[email protected]